Hangzhou Minsheng Healthcare Co Ltd Asset Resilience Ratio

Latest as of June 2026: 21.12%

Hangzhou Minsheng Healthcare Co Ltd asset resilience ratio. Hangzhou Minsheng Healthcare Co Ltd (301507) has an Asset Resilience Ratio of 21.12% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See defensive interval ratio of Hangzhou Minsheng Healthcare Co Ltd to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥444.43 Million
≈ $65.03 Million USD Cash + Short-term Investments

Total Assets

CN¥2.10 Billion
≈ $307.91 Million USD All company assets

Resilience Assessment

Good
Financial Resilience Level

Asset Resilience Ratio of Hangzhou Minsheng Healthcare Co Ltd (2021–2025)

Asset resilience ratio of Hangzhou Minsheng Healthcare Co Ltd from 2021 to 2025. This chart shows how Hangzhou Minsheng Healthcare Co Ltd's Asset Resilience Ratio has changed over time. Read 301507 liabilities breakdown for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Hangzhou Minsheng Healthcare Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see balance sheet size of Hangzhou Minsheng Healthcare Co Ltd.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥444.43 Million 21.12%
Total Liquid Assets CN¥444.43 Million 21.12%

Asset Resilience Insights

  • Good Liquidity Position: Hangzhou Minsheng Healthcare Co Ltd maintains a healthy 21.12% of assets in liquid form.
  • This level provides good financial flexibility while maintaining productive asset deployment.
  • The company has significant short-term investments, indicating active treasury management.

Hangzhou Minsheng Healthcare Co Ltd Industry Peers by Asset Resilience Ratio

Compare Hangzhou Minsheng Healthcare Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Merck & Company Inc
NYSE:MRK
Drug Manufacturers - General 0.22%
AstraZeneca PLC
NASDAQ:AZN
Drug Manufacturers - General 0.10%
Pfizer Inc
SA:PFIZ34
Drug Manufacturers - General 5.33%
Novartis AG
MX:NVSN
Drug Manufacturers - General 0.08%
Pfizer Inc
NYSE:PFE
Drug Manufacturers - General 5.33%
Novo Nordisk A/S
CO:NOVO-B
Drug Manufacturers - General 0.09%
Zhejiang Int'L Group Co Ltd
SHE:000411
Drug Manufacturers - General 0.00%
SANOFI CONS HEALTHC IND L
NSE:SANOFICONR
Drug Manufacturers - General 0.07%

Hangzhou Minsheng Healthcare Co Ltd Asset Resilience Ratio by Year (2021–2025)

Hangzhou Minsheng Healthcare Co Ltd asset resilience ratio by year from 2021 to 2025. The table below shows the annual Asset Resilience Ratio data for Hangzhou Minsheng Healthcare Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 26.88% CN¥542.28 Million
≈ $79.35 Million
CN¥2.02 Billion
≈ $295.16 Million
-1.56pp
2024-12-31 28.44% CN¥496.20 Million
≈ $72.61 Million
CN¥1.74 Billion
≈ $255.29 Million
+9.22pp
2023-12-31 19.22% CN¥316.70 Million
≈ $46.34 Million
CN¥1.65 Billion
≈ $241.13 Million
+11.62pp
2022-12-31 7.60% CN¥58.14 Million
≈ $8.51 Million
CN¥765.29 Million
≈ $111.99 Million
-26.64pp
2021-12-31 34.23% CN¥233.30 Million
≈ $34.14 Million
CN¥681.49 Million
≈ $99.72 Million
--
pp = percentage points

About Hangzhou Minsheng Healthcare Co Ltd

SHE:301507 China Drug Manufacturers - General
Market Cap
$616.19 Million
CN¥4.21 Billion CNY
Market Cap Rank
#10892 Global
#2943 in China
Share Price
CN¥11.81
Change (1 day)
-0.84%
52-Week Range
CN¥11.29 - CN¥17.79
All Time High
CN¥32.51
About

Hangzhou Minsheng Healthcare Co., Ltd. engages in the research, development, production, and sale of vitamins and mineral supplements, OTC drugs, and healthy foods in China and internationally. The company offers healthy products, such as fish and algae oil gel candy, collagen peptide vitamin D calcium chewable tablets, blueberry lutein ester candy tablets, and probiotic solid beverage. It also p… Read more